ACCLX | MVCAX | ACCLX / MVCAX | |
Total Expense Ratio | 1.97 | 0.99 | 199% |
Annual Report Gross Expense Ratio | 1.97 | 1.00 | 197% |
Fund Existence | 16 years | 24 years | - |
Gain YTD | 8.143 | 5.508 | 148% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7B | 17.3B | 40% |
Annual Yield % from dividends | 0.61 | 0.84 | 73% |
Returns for 1 year | 0.06 | -2.57 | -2% |
Returns for 3 years | 8.92 | 18.36 | 49% |
Returns for 5 years | 13.03 | 52.00 | 25% |
Returns for 10 years | 9.73 | 75.57 | 13% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QCLN | 38.26 | 0.80 | +2.14% |
First Trust NASDAQ® Cln Edge® GrnEngyETF | |||
HBMBF | 219.20 | N/A | N/A |
HBM Bioventures AG | |||
DECT | 34.57 | -0.07 | -0.21% |
AllianzIM U.S. Large Cp Buffer10 Dec ETF | |||
PTLC | 53.09 | -0.16 | -0.30% |
Pacer Trendpilot™ US Large Cap ETF | |||
BCDF | 30.56 | -0.20 | -0.66% |
Horizon Kinetics Blockchain Dev ETF |